WILEX AG

 

 

ENGLISH DEUTSCH

Focused on oncology, WILEX develops diagnostic and therapeutic product candidates based on antibodies, which are available for out-licensing. The subsidiary Heidelberg Pharma GmbH offers preclinical contract research services and an antibody drug conjugate (ADC) technology platform.

 

Latest News

15.10.2014: WILEX publishes 9-month Financial Report 2014....More

14.10.2014: WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche .....More

 

Seite gelesen: 193553 | Heute: 9